ebook Munafa Stock Market Course + Intraday & FNO calls  

       

SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE

Sun Pharma Advanced Research Company Limited Complete list of announcements declared & dividend announcements by Sun Pharma Advanced Research Company Limited SPARC

Sun Pharma Advanced Research Company Limited SPARC listed on NSE and deals in Pharmaceuticals

Announcements and dividends declared by Sun Pharma Advanced Research Company Limited SPARC

Sun Pharma plans billion local debt sale for loan takeout, sources say
Sun Pharma is planning to raise about Rs 10,000 crore through rupee-denominated bonds to partly refinance a bridge loan used for its Organon acquisition, according to Reuters. The drugmaker is expected to issue two-, three- and four-year bonds as Indian co
Announcement as on 29 September 2026

Expanding innovative portfolio may drive gains for Sun Pharma stock
Lerodalcibep licensing deal, growth in the US portfolio and tariff relief offer triggers, while the proposed Organon acquisition could broaden its global reach
Announcement as on 29 September 2026

Sun Pharma bags rights to .7 billion cholesterol drug market globally
Sun Pharma will commercialise and manufacture LIB Therapeutics' once-monthly cholesterol drug outside the US and China after its EU approval
Announcement as on 28 September 2026

Sun Pharma signs major deal with LIB Therapeutics of US, gains access to .7-bn global market for bad cholesterol inhibitor PCSK9
Sun Pharma has signed an exclusive agreement with LIB Therapeutics for Lerodalcibep, a cholesterol-lowering medication. This deal covers all markets globally except for the United States and China. Lerodalcibep, a once-monthly PCSK9 inhibitor, will be mark
Announcement as on 28 September 2026

Company Announcement
Sun Pharma Advanced Research Company Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
Announcement as on 25 September 2026

Announcements by Sun Pharma Advanced Research Company Limited first page | Next page | Prev page |

SPARC Sun Pharma Advanced Research Company Limited current price & indicator signals

Moving Averages for Sun Pharma Advanced Research Company Limited

  • 5Day Average: 183.39
  • 12Day Average: 180.37
  • 20Day Average: 183.27
  • 50Day Average: 192.38
  • 100Day Average: 209.01
  • 150Day Average: 195.65
  • 200Day Average: 178.65

SPARC Indicators & signals

Indicator MACD (12,26,9)

184.13, 186.53, -4.26
Indicator MACD is in negative zone

Indicator ADX (14)

16.28, 27.65, 19.91
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 57
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of SPARC Sun Pharma Advanced Research Company Limited are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
06 Fri Nov 2026 193.52 189.85 to 196.72 -1.35% 1.08 times
05 Thu Nov 2026 196.16 185.49 to 200.09 11.62% 2.87 times
03 Tue Nov 2026 175.74 170.61 to 180.30 0.37% 1 times
02 Mon Nov 2026 175.09 173.41 to 179.05 -0.78% 0.63 times
30 Fri Oct 2026 176.46 175.25 to 183.90 -3.56% 0.81 times
29 Thu Oct 2026 182.98 180.50 to 184.90 0.18% 0.41 times
28 Wed Oct 2026 182.66 178.35 to 184.30 1.91% 0.54 times
27 Tue Oct 2026 179.24 175.70 to 181.27 0.47% 0.64 times
26 Mon Oct 2026 178.40 169.83 to 185.15 3.86% 1.3 times
23 Fri Oct 2026 171.77 167.22 to 174.65 -0.76% 0.99 times
22 Thu Oct 2026 173.09 171.82 to 178.00 -3.45% 0.82 times
21 Wed Oct 2026 179.27 176.58 to 186.01 -3.13% 1.02 times

Videos related to: SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

SPARC announcements Sun Pharma Advanced Research Company Limited announcements and dividends declared NSE

 

Back to top